A telomere protein shapes aging from within cells

Telomeres are the protective caps at the ends of chromosomes. With each cell division they shorten slightly. When they become too short, the cell stops dividing or enters a harmful state that contributes to aging. TERT is the enzyme that can lengthen telomeres. It has been known for decades, but a new perspective article in Nature Aging shows that TERT’s role in aging is far broader than telomere maintenance alone.

TERT acts far beyond chromosome ends

Beyond its classical function, TERT has so-called non-canonical roles: it regulates gene activity, protects mitochondria, and influences inflammatory processes. This makes the protein relevant to multiple aging mechanisms at once. According to the researchers, this is reason to consider TERT a central regulatory hub in the aging process, not merely a component of the telomere machinery.

The article also discusses the challenges of targeting TERT therapeutically. Activating TERT can extend cell division, but in certain contexts it also promotes tumour growth, since cancer cells frequently activate TERT themselves. Finding a therapeutic window that slows aging without increasing cancer risk is a central challenge.

A framework for future interventions

The authors present a framework for evaluating TERT- and telomere-directed strategies. They distinguish interventions targeting telomere length, TERT enzyme activity, and the broader regulatory functions of the protein. Each type carries different risk profiles and requires different evaluation criteria.

This is a perspective article, not a new experimental study. It synthesises existing knowledge and proposes a research agenda. Concrete clinical applications remain distant, but the article provides a useful overview of the current state of this subfield of longevity science.

Read the original article